Floatz logo

Zinc Acetate Dihydrate

Development Delay

Children's University Hospital Cologne, GermanyPhase 2Active
B
57/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
42/ 100
Competitive Position
95/ 100

Competitive context

1 Active assets in the Development Delay cohort.

Asset / SponsorPhaseRating
Induced pluripotent stem cells (iPSCs)
University of Missouri-Columbia
D

Same molecule, other indications

Zinc Acetate Dihydrate is also rated in:

dystonic disorderDormant
B
Indicative ·
57 / 100
View asset →
epilepsyDormant
CCC
Indicative ·
54 / 100
View asset →
neurodevelopmental disorder with involuntary movementsDormant
NR
Indicative ·
/ 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →